Clinical Trial

Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation

Recruiting
View on ClinicalTrials.gov →
Summary
The aim is to investigate whether optimizing patients' expectations towards the interventional treatment of atrial fibrillation (catheter ablation) leads to a lower disease-related impairment of the patients compared to the control group in the first three months after ablation (the so-called blanking period).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-09-27; most recent amendment 2026-04-27.
Trial Details
NCT Number NCT05557526
Lead Sponsor Evangelical Hospital Düsseldorf
Collaborators: University Hospital, Essen
Conditions Atrial Fibrillation
Enrollment 60 participants
Start Date 2022-06-09
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-28